Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05764824 · ClinicalTrials.gov registry record · NA

Long-term Effects of Blueberry Supplementation on Brain Health in Older Adults

A NA study of Cognitive Decline and Nutrition, Healthy, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
67
Enrollment target
1
Study location

NCT05764824 is a NA study of Cognitive Decline and Nutrition, Healthy that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 67 participants, below the 1,148-participant average among 61 other Cognitive Decline trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05764824, a NA study of Cognitive Decline and Nutrition, Healthy, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
67 participants
Enrollment target
1
Study location

Study Summary

This study will test whether consuming blueberry powder 20g/d for 24 weeks can improve memory and other cognitive function and alter serum biomarkers of brain injury among older adults.

Interventions

  • DIETARY_SUPPLEMENT Blueberry powder
  • OTHER Controlled and matched powder

Study Locations (1)

Massachusetts

  • Mass General Brigham - Boston

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2023-10-01
Est. Completion 2024-09-11
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT05764824

The ClinicalTrials.gov registry entry for NCT05764824 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,148-participant average among 61 other Cognitive Decline trials with a reported enrollment target (94% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cognitive Decline appearing as the primary indexed condition, and to 2 interventions - of which Blueberry powder is the first listed.

NCT05764824 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05764824 about?

NCT05764824 is a clinical study titled "Long-term Effects of Blueberry Supplementation on Brain Health in Older Adults". This study will test whether consuming blueberry powder 20g/d for 24 weeks can improve memory and other cognitive function and alter serum biomarkers of brain injury among older adults.

What is the current status of trial NCT05764824?

This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2023-10-01. Estimated completion is 2024-09-11.

What conditions does trial NCT05764824 study?

This clinical trial studies the following conditions: Cognitive Decline, Nutrition, Healthy, Brain Injuries.

What interventions are being tested in trial NCT05764824?

The interventions under investigation include: Blueberry powder (DIETARY_SUPPLEMENT), Controlled and matched powder (OTHER).

Who is sponsoring clinical trial NCT05764824?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05764824 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Decline

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.